About
Ken Tam is a postdoctoral researcher at the School of Pharmacy and Pharmaceutical Sciences, University of Liverpool. He began his professional career as a pharmacist before transitioning into academic research, where he developed a strong interest in translational technologies that address practical, real-world challenges. He holds a PhD in Pharmaceutics from the University of East Anglia, where he began his academic career within the School of Pharmacy.
Ken’s research background spans additive manufacturing and personalised medicine, with a particular focus on the development of 3D-printed pharmaceutical dosage forms. His work explores tailored drug delivery systems and enabling technologies that support more precise, patient-centred therapies. Alongside his doctoral research, he contributed to several early-stage innovation projects, including the development of a natural antimicrobial food spray to extend the shelf life of salmon during transport, seaweed-derived prototype packaging aimed at reducing plastic use, and compostable material solutions for cosmetic product packaging.
He is currently involved in a European Innovation Council (EIC)–funded programme focused on the development of 3D-printed personalised polypills designed to reduce medication burden. His role centres on the formulation and optimisation of pharmaceutical materials that enable advanced manufacturing processes.
Ken’s research bridges material science, pharmaceutical formulation, and translational healthcare. His work primarily focuses on pharmaceutical materials, with extensions into biomaterials and natural polymers, driven by the goal of creating functional materials for health technologies and sustainable applications. Across his research, he examines how composition, processing, and microstructure influence material performance in real-world systems, with a strong emphasis on translating laboratory innovations into clinically relevant solutions.